Clinical Trial Update: Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Botox (onabotulinumtoxinA) with topiramate for the prevention of chronic migraine in adults. The study evaluated comparative efficacy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Topamax (Topiramate)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Phase 4 | Status: COMPLETED | Results posted: 2018-06-07